Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications
2000
SCF splice variants in melanoma and melanocytes
Sample size: 11
publication
Author Information
Author(s): Welker P, Schadendorf D, Artuc M, Grabbe J, Henz B M
Primary Institution: Department of Dermatology, Charité, Humboldt University, Berlin, Germany
Hypothesis
The study investigates the prognostic significance of SCF splice variants in melanoma.
Conclusion
The study suggests that SCF-2 may serve as a prognostic marker for malignant melanoma.
Supporting Evidence
- Nine of the 11 melanoma cell lines expressed SCF-1 mRNA.
- Only two melanoma cell lines expressed SCF-2 mRNA, and these also expressed SCF-1.
- Coexpression of both SCF-1 and c-Kit was noted in five cell lines.
Takeaway
Researchers looked at certain proteins in skin cells and melanoma cells to see if they could help predict how serious the melanoma is.
Methodology
The study used reverse transcription polymerase chain reaction, immunocytochemistry, and enzyme-linked immunosorbent assay to analyze SCF and c-Kit expression.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website